These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Effect of Preterm Birth on Cardiac and Cardiomyocyte Growth and the Consequences of Antenatal and Postnatal Glucocorticoid Treatment. Vrselja A; Pillow JJ; Black MJ J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501343 [TBL] [Abstract][Full Text] [Related]
46. Cost-benefit of antenatal glucocorticoid therapy: There is still much more to learn. Nathanielsz PW BJOG; 2023 Mar; 130(4):334-335. PubMed ID: 36424900 [No Abstract] [Full Text] [Related]
47. [Intrauterine determination of fetal weight according to Stroikova]. DAVYDOV VI Kazan Med Zh; 1961; 5():58-9. PubMed ID: 13884002 [No Abstract] [Full Text] [Related]
48. Antenatal, perinatal, and primordial cardiovascular prevention: What is known, what is happening, and future directions. Pedretti RFE Eur J Prev Cardiol; 2021 May; 28(4):359-360. PubMed ID: 31838878 [No Abstract] [Full Text] [Related]
49. The role of ultrasound in the diagnosis and management of the growth restricted fetus. Lee S; Walker SP Australas J Ultrasound Med; 2010 Aug; 13(3):31-36. PubMed ID: 28191088 [No Abstract] [Full Text] [Related]
50. Transferring an extremely premature infant to an extra-uterine life support system: a prospective view on the obstetric procedure. van Haren JS; Delbressine FLM; Schoberer M; Te Pas AB; van Laar JOEH; Oei SG; van der Hout-van der Jagt MB Front Pediatr; 2024; 12():1360111. PubMed ID: 38425664 [TBL] [Abstract][Full Text] [Related]
51. Association of Antenatal Corticosteroids With Mortality, Morbidity, and Neurodevelopmental Outcomes in Extremely Preterm Multiple Gestation Infants. Boghossian NS; McDonald SA; Bell EF; Carlo WA; Brumbaugh JE; Stoll BJ; Laptook AR; Shankaran S; Walsh MC; Das A; Higgins RD; JAMA Pediatr; 2016 Jun; 170(6):593-601. PubMed ID: 27088897 [TBL] [Abstract][Full Text] [Related]
52. The Effects of Antenatal Corticosteroids on Short- and Long-Term Outcomes in Small-for-Gestational-Age Infants. Ishikawa H; Miyazaki K; Ikeda T; Murabayashi N; Hayashi K; Kai A; Ishikawa K; Miyamoto Y; Nishimura K; Kono Y; Kusuda S; Fujimura M; Int J Med Sci; 2015; 12(4):295-300. PubMed ID: 25897289 [TBL] [Abstract][Full Text] [Related]
53. Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses? Morrison JL; Botting KJ; Soo PS; McGillick EV; Hiscock J; Zhang S; McMillen IC; Orgeig S J Pregnancy; 2012; 2012():839656. PubMed ID: 23227338 [TBL] [Abstract][Full Text] [Related]
54. Antenatal glucocorticoids reduce growth in appropriately grown and growth-restricted ovine fetuses in a sex-specific manner. Miller SL; Sutherland AE; Supramaniam VG; Walker DW; Jenkin G; Wallace EM Reprod Fertil Dev; 2012; 24(5):753-8. PubMed ID: 22697125 [TBL] [Abstract][Full Text] [Related]
55. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks]. Kinalski M; Sledziewski A; Kretowski A Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922 [TBL] [Abstract][Full Text] [Related]
56. Mending a growth-restricted fetal heart: should we use glucocorticoids? Hodges RJ; Wallace EM J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2149-53. PubMed ID: 22764774 [TBL] [Abstract][Full Text] [Related]
57. Cardiovascular responses to maternal betamethasone administration in the intrauterine growth-restricted ovine fetus. Miller SL; Supramaniam VG; Jenkin G; Walker DW; Wallace EM Am J Obstet Gynecol; 2009 Dec; 201(6):613.e1-8. PubMed ID: 19766978 [TBL] [Abstract][Full Text] [Related]